Literature DB >> 11023138

Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.

E W ter Braak1, A M Appelman, M van de Laak, R P Stolk, T W van Haeften, D W Erkelens.   

Abstract

OBJECTIVE: To investigate the frequency of severe hypoglycemia (SH) and hypoglycemic coma and to identify clinical and behavioral risk indicators in a nonselected population of type 1 diabetic patients. RESEARCH DESIGN AND METHODS: This study involved a retrospective clinical survey of 195 consecutive patients using a questionnaire addressing the frequency of SH (i.e., help from others required) and hypoglycemic coma during the previous year, general characteristics, behavior, hypoglycemia awareness, and the Hypoglycemia Fear Survey Data regarding diabetes, treatment, long-term complications, comorbidity, and comedication were obtained from the patients' medical records.
RESULTS: A total of 82% of subjects were receiving intensive insulin treatment, and mean +/- SD HbA(1c) was 7.8 +/- 1.2%. Mean duration of diabetes was 20 +/- 12 years. The occurrence of SH (including hypoglycemic coma) was 150 episodes/100 patient-years and affected 40.5% of the population. Hypoglycemic coma occurred in 19% of subjects (40 episodes/100 patient-years). SH without coma was independently related to nephropathy (odds ratio [OR] 4.8 [95% CI 1.5-15.1]), a threshold for hypoglycemic symptoms of <3 mmol/l (4.8 [1.8-12.0]), and a daily insulin dose 0.1 U/kg higher (1.3 [1.0-1.6]) (all ORs were adjusted for diabetes duration and use of comedication). Hypoglycemic coma was independently related to neuropathy (3.9 [1.5-10.4]), (nonselective) beta-blocking agents (14.9 [2.1-107.4]), and alcohol use (3.5 [1.3-9.1]) (all ORs were adjusted for diabetes duration).
CONCLUSIONS: SH and hypoglycemic coma are common in a nonselected population with type 1 diabetes. The presence of long-term complications, a threshold for symptoms of <3 mmo/l, alcohol use, and (nonselective) beta-blockers were associated with SH during the previous year. If prospectively confirmed, these results may have consequences for clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023138     DOI: 10.2337/diacare.23.10.1467

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

1.  Management of Type 1 Diabetes in Older Adults.

Authors:  Ruban Dhaliwal; Ruth S Weinstock
Journal:  Diabetes Spectr       Date:  2014-02

Review 2.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

3.  Patient and family expectations of beta-cell replacement therapies in type 1 diabetes.

Authors:  Akitsu Kawabe; Shinichi Matsumoto; Masayuki Shimoda
Journal:  Islets       Date:  2018-08-17       Impact factor: 2.694

4.  Severe hypoglycaemia in drug-treated diabetic patients needs attention: a population-based study.

Authors:  Mikko T Honkasalo; Outi M Elonheimo; Timo Sane
Journal:  Scand J Prim Health Care       Date:  2011-06-15       Impact factor: 2.581

5.  Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Alexandra K Lee; Clare J Lee; Elbert S Huang; A Richey Sharrett; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2017-09-19       Impact factor: 19.112

6.  Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible?

Authors:  Marie Moth Henriksen; Louise Færch; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

7.  Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.

Authors:  E S Kilpatrick; A S Rigby; K Goode; S L Atkin
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

8.  Diabetes increases brain damage caused by severe hypoglycemia.

Authors:  Adam J Bree; Erwin C Puente; Dorit Daphna-Iken; Simon J Fisher
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-12       Impact factor: 4.310

9.  Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes.

Authors:  Trang T Ly; Patricia H Gallego; Elizabeth A Davis; Timothy W Jones
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 19.112

10.  Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Authors:  Erwin C Puente; Julie Silverstein; Adam J Bree; Daniel R Musikantow; David F Wozniak; Susan Maloney; Dorit Daphna-Iken; Simon J Fisher
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.